# Effect of Oral L-carnitine Supplement on Lipid Profile, Anemia, and Quality of Life of Patients

> **NCT01278693** · PHASE2 · COMPLETED · sponsor: **Isfahan University of Medical Sciences** · enrollment: 54 (actual)

## Conditions studied

- Complication of Hemodialysis

## Interventions

- **DRUG:** L-carnitine
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01278693
- **Lead sponsor:** Isfahan University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08
- **Primary completion:** 2010-09
- **Final completion:** 2010-09
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2011-01-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01278693

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01278693, "Effect of Oral L-carnitine Supplement on Lipid Profile, Anemia, and Quality of Life of Patients". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT01278693. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*